ArticleTherapeutic advances in gastroenterology2022

Risk of consecutive immunogenic failure in switchers of anti-tumor necrosis factor alpha among patients with inflammatory bowel diseases.

Henit Yanai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.